CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hainan Biomedical Device Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hainan Biomedical Device Co., Ltd.
Phone: +86 89863835005p:+86 89863835005 HAN  571200  China Ticker: 920268920268

Business Summary
Hainan Biomedical Device Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of surgical medical devices represented by surgical sutures, as well as peptide pharmaceutical equipment and related products. The Company operates its businesses through two segments. The Medical Device Manufacturing and Sales segment mainly provides surgical device products, including surgical sutures, interventional embolization materials and hemostatic materials. The Pharmaceutical Equipment Manufacturing and Sales segment mainly provides peptide pharmaceutical equipment products, including peptide synthesizers and peptide cleavage systems. The Company mainly conducts its businesses in the domestic market.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202512/31/2025-----

General Information
Number of Employees: 397 (As of 12/31/2025)
Outstanding Shares: 54,200,000 (As of 9/9/2026)
Stock Exchange: BJS
Fax Number: +86 89863835005


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, October 18, 2026